Poultry Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application (Broiler, Layer, Breeder), By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines), By Disease Type (Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus, Duck Viral Enteritis, Inclusion Body Hepatitis, Salmonella, Others), By Region and Competition, 2020-2030F
Market Overview
The Global Poultry Vaccines Market was valued at USD 1.89 billion in 2024 and is projected t%li%reach USD 2.78 billion by 2030, growing at a CAGR of 6.64% during the forecast period. As poultry farming remains a cornerstone of the global food supply, the market for poultry vaccines plays a vital role in maintaining flock health and ensuring food security. The increasing prevalence of avian diseases, such as Infectious Bursal Disease (IBD), coupled with the growing popularity of poultry products, is driving the demand for effective immunization strategies. Recent zoonotic outbreaks and the rising incidence of viral infections in poultry, particularly in regions like Africa and Asia, are further emphasizing the need for widespread vaccination programs. Technological advancements in vaccine development, including recombinant and DNA-based vaccines, are contributing t%li%the market's evolution. Moreover, governments and veterinary organizations are increasingly focused on disease control t%li%prevent economic losses in the poultry industry, reinforcing the importance of vaccines in sustaining productivity and health standards in poultry farming.
Key Market Drivers
Rising Global Poultry Consumption
The steady increase in global poultry consumption is significantly contributing t%li%the expansion of the poultry vaccines market. Poultry, particularly chicken, has become a preferred protein source due t%li%its affordability, nutritional value, and adaptability in diverse cuisines. As populations grow and urbanization accelerates, the demand for poultry meat and eggs continues t%li%rise. This surge in consumption amplifies the need for disease prevention t%li%protect flock health and ensure stable supply chains. Poultry farming is highly susceptible t%li%disease outbreaks, which can result in massive financial losses and disruptions in production. Diseases like Newcastle disease, avian influenza, and coccidiosis are particularly prevalent and costly. For instance, a study reported in IJCMAS in October 2021 detailed financial losses ranging from INR 17,864 (USD 214) t%li%INR 2,66,080 (USD 3,188.89) per farm due t%li%Newcastle disease, further highlighting the critical need for robust vaccination programs. As a result, maintaining flock health through vaccination is becoming a key strategy for producers t%li%safeguard economic returns and meet growing consumer demand.
Key Market Challenges
Disease Complexity and Variability
The poultry vaccines market faces notable challenges stemming from the complexity and variability of infectious diseases affecting poultry. Poultry are vulnerable t%li%a broad spectrum of pathogens, including viruses, bacteria, and parasites, each with multiple strains and high mutation rates. This diversity complicates the development of vaccines that can offer comprehensive and long-lasting protection. Continual pathogen evolution necessitates constant updates in vaccine formulations, increasing research and development costs. Moreover, the unpredictable emergence of novel variants can outpace the availability of suitable vaccines, undermining disease control efforts and adding uncertainty t%li%vaccine efficacy.
Key Market Trends
Precision Vaccination
Precision vaccination is emerging as a key trend in the poultry vaccines market, with the focus shifting toward more targeted and efficient immunization strategies. This approach tailors vaccination programs based on specific factors such as the age, health status, and risk profile of poultry flocks. Through the use of data analytics and advanced monitoring systems, precision vaccination enables better disease forecasting and more accurate administration schedules. The result is enhanced vaccine effectiveness, reduced wastage, and cost optimization. This trend aligns with the broader movement toward data-driven, sustainable practices in animal agriculture and reflects the industry’s commitment t%li%maximizing productivity while minimizing intervention-related costs.
Key Market Players
In this report, the Global Poultry Vaccines Market has been segmented int%li%the following categories, in addition t%li%the industry trends which have als%li%been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Poultry Vaccines Market.
Available Customizations:
Global Poultry Vaccines market report with the given market data, TechSci Research offers customizations according t%li%a company's specific needs. The following customization options are available for the report:
Company Information
The Global Poultry Vaccines Market was valued at USD 1.89 billion in 2024 and is projected t%li%reach USD 2.78 billion by 2030, growing at a CAGR of 6.64% during the forecast period. As poultry farming remains a cornerstone of the global food supply, the market for poultry vaccines plays a vital role in maintaining flock health and ensuring food security. The increasing prevalence of avian diseases, such as Infectious Bursal Disease (IBD), coupled with the growing popularity of poultry products, is driving the demand for effective immunization strategies. Recent zoonotic outbreaks and the rising incidence of viral infections in poultry, particularly in regions like Africa and Asia, are further emphasizing the need for widespread vaccination programs. Technological advancements in vaccine development, including recombinant and DNA-based vaccines, are contributing t%li%the market's evolution. Moreover, governments and veterinary organizations are increasingly focused on disease control t%li%prevent economic losses in the poultry industry, reinforcing the importance of vaccines in sustaining productivity and health standards in poultry farming.
Key Market Drivers
Rising Global Poultry Consumption
The steady increase in global poultry consumption is significantly contributing t%li%the expansion of the poultry vaccines market. Poultry, particularly chicken, has become a preferred protein source due t%li%its affordability, nutritional value, and adaptability in diverse cuisines. As populations grow and urbanization accelerates, the demand for poultry meat and eggs continues t%li%rise. This surge in consumption amplifies the need for disease prevention t%li%protect flock health and ensure stable supply chains. Poultry farming is highly susceptible t%li%disease outbreaks, which can result in massive financial losses and disruptions in production. Diseases like Newcastle disease, avian influenza, and coccidiosis are particularly prevalent and costly. For instance, a study reported in IJCMAS in October 2021 detailed financial losses ranging from INR 17,864 (USD 214) t%li%INR 2,66,080 (USD 3,188.89) per farm due t%li%Newcastle disease, further highlighting the critical need for robust vaccination programs. As a result, maintaining flock health through vaccination is becoming a key strategy for producers t%li%safeguard economic returns and meet growing consumer demand.
Key Market Challenges
Disease Complexity and Variability
The poultry vaccines market faces notable challenges stemming from the complexity and variability of infectious diseases affecting poultry. Poultry are vulnerable t%li%a broad spectrum of pathogens, including viruses, bacteria, and parasites, each with multiple strains and high mutation rates. This diversity complicates the development of vaccines that can offer comprehensive and long-lasting protection. Continual pathogen evolution necessitates constant updates in vaccine formulations, increasing research and development costs. Moreover, the unpredictable emergence of novel variants can outpace the availability of suitable vaccines, undermining disease control efforts and adding uncertainty t%li%vaccine efficacy.
Key Market Trends
Precision Vaccination
Precision vaccination is emerging as a key trend in the poultry vaccines market, with the focus shifting toward more targeted and efficient immunization strategies. This approach tailors vaccination programs based on specific factors such as the age, health status, and risk profile of poultry flocks. Through the use of data analytics and advanced monitoring systems, precision vaccination enables better disease forecasting and more accurate administration schedules. The result is enhanced vaccine effectiveness, reduced wastage, and cost optimization. This trend aligns with the broader movement toward data-driven, sustainable practices in animal agriculture and reflects the industry’s commitment t%li%maximizing productivity while minimizing intervention-related costs.
Key Market Players
- Boehringer Ingelheim GmbH
- Zoetis Inc
- Elanc%li%LLC
- Intervet Inc
- Hester Biosciences Ltd
- Vaxxinova GmbH
- Venky's India Ltd
- Laboratorios Calier SA
- KM Biologics C%li%Ltd
- Phibr%li%Animal Health Corporation
In this report, the Global Poultry Vaccines Market has been segmented int%li%the following categories, in addition t%li%the industry trends which have als%li%been detailed below:
- Poultry Vaccines Market, By Application:
- Broiler
- Layer
- Breeder
- Poultry Vaccines Market, By Product:
- Attenuated Live Vaccines
- Inactivated Vaccines
- Subunit Vaccines
- DNA Vaccines
- Recombinant Vaccines
- Poultry Vaccines Market, By Disease Type:
- Infectious Bronchitis
- Infectious Bursal Diseases
- Infectious Laryngotracheitis
- Egg Drop Syndrome
- Adenovirus
- Duck Viral Enteritis
- Inclusion Body Hepatitis
- Salmonella
- Others
- Poultry Vaccines Market, By Region:
- North America
- United States
- Mexico
- Canada
- Europe
- France
- Germany
- United Kingdom
- Italy
- Spain
- Asia-Pacific
- China
- India
- South Korea
- Japan
- Australia
- South America
- Brazil
- Argentina
- Colombia
- Middle East and Africa
- South Africa
- Saudi Arabia
- UAE
Company Profiles: Detailed analysis of the major companies present in the Global Poultry Vaccines Market.
Available Customizations:
Global Poultry Vaccines market report with the given market data, TechSci Research offers customizations according t%li%a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up t%li%five).
1. PRODUCT OVERVIEW
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL POULTRY VACCINES MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Application (Broiler, Layer, Breeder)
5.2.2. By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines)
5.2.3. By Disease Type (Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus, Duck Viral Enteritis, Inclusion Body Hepatitis, Salmonella, Others)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Product Market Map
5.3.1. By Application
5.3.2. By Product
5.3.3. By Disease Type
5.3.4. By Region
6. NORTH AMERICA POULTRY VACCINES MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Application (Broiler, Layer, Breeder)
6.2.2. By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines)
6.2.3. By Disease Type (Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus, Duck Viral Enteritis, Inclusion Body Hepatitis, Salmonella, Others)
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Poultry Vaccines Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Application
6.3.1.2.2. By Product
6.3.1.2.3. By Disease Type
6.3.2. Canada Poultry Vaccines Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Application
6.3.2.2.2. By Product
6.3.2.2.3. By Disease Type
6.3.3. Mexico Poultry Vaccines Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Application
6.3.3.2.2. By Product
6.3.3.2.3. By Disease Type
7. EUROPE POULTRY VACCINES MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Application (Broiler, Layer, Breeder)
7.2.2. By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines)
7.2.3. By Disease Type (Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus, Duck Viral Enteritis, Inclusion Body Hepatitis, Salmonella, Others)
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Poultry Vaccines Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Application
7.3.1.2.2. By Product
7.3.1.2.3. By Disease Type
7.3.2. United Kingdom Poultry Vaccines Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Application
7.3.2.2.2. By Product
7.3.2.2.3. By Disease Type
7.3.3. France Poultry Vaccines Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Application
7.3.3.2.2. By Product
7.3.3.2.3. By Disease Type
7.3.4. Italy Poultry Vaccines Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Application
7.3.4.2.2. By Product
7.3.4.2.3. By Disease Type
7.3.5. Spain Poultry Vaccines Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Application
7.3.5.2.2. By Product
7.3.5.2.3. By Disease Type
8. ASIA-PACIFIC POULTRY VACCINES MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Application (Broiler, Layer, Breeder)
8.2.2. By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines)
8.2.3. By Disease Type (Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus, Duck Viral Enteritis, Inclusion Body Hepatitis, Salmonella, Others)
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Poultry Vaccines Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Application
8.3.1.2.2. By Product
8.3.1.2.3. By Disease Type
8.3.2. Japan Poultry Vaccines Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Application
8.3.2.2.2. By Product
8.3.2.2.3. By Disease Type
8.3.3. India Poultry Vaccines Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Application
8.3.3.2.2. By Product
8.3.3.2.3. By Disease Type
8.3.4. Australia Poultry Vaccines Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Application
8.3.4.2.2. By Product
8.3.4.2.3. By Disease Type
8.3.5. South Korea Poultry Vaccines Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Application
8.3.5.2.2. By Product
8.3.5.2.3. By Disease Type
9. SOUTH AMERICA POULTRY VACCINES MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Application (Broiler, Layer, Breeder)
9.2.2. By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines)
9.2.3. By Disease Type (Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus, Duck Viral Enteritis, Inclusion Body Hepatitis, Salmonella, Others)
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Poultry Vaccines Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Application
9.3.1.2.2. By Product
9.3.1.2.3. By Disease Type
9.3.2. Argentina Poultry Vaccines Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Application
9.3.2.2.2. By Product
9.3.2.2.3. By Disease Type
9.3.3. Colombia Poultry Vaccines Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Application
9.3.3.2.2. By Product
9.3.3.2.3. By Disease Type
10. MIDDLE EAST AND AFRICA POULTRY VACCINES MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Application (Broiler, Layer, Breeder)
10.2.2. By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines)
10.2.3. By Disease Type (Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus, Duck Viral Enteritis, Inclusion Body Hepatitis, Salmonella, Others)
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Poultry Vaccines Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Application
10.3.1.2.2. By Product
10.3.1.2.3. By Disease Type
10.3.2. Saudi Arabia Poultry Vaccines Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Application
10.3.2.2.2. By Product
10.3.2.2.3. By Disease Type
10.3.3. UAE Poultry Vaccines Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Application
10.3.3.2.2. By Product
10.3.3.2.3. By Disease Type
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches
13. PORTER’S FIVE FORCES ANALYSIS
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products
14. COMPETITIVE LANDSCAPE
14.1. Boehringer Ingelheim GmbH
14.1.1. Business Overview
14.1.2. Company Snapshot
14.1.3. Products & Services
14.1.4. Financials (As Reported)
14.1.5. Recent Developments
14.1.6. Key Personnel Details
14.1.7. SWOT Analysis
14.2. Zoetis Inc
14.3. Elanco LLC
14.4. Intervet Inc
14.5. Hester Biosciences Ltd
14.6. Vaxxinova GmbH
14.7. Venky's India Ltd
14.8. Laboratorios Calier SA
14.9. KM Biologics Co Ltd
14.10. Phibro Animal Health Corporation
15. STRATEGIC RECOMMENDATIONS
16. ABOUT US & DISCLAIMER
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL POULTRY VACCINES MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Application (Broiler, Layer, Breeder)
5.2.2. By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines)
5.2.3. By Disease Type (Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus, Duck Viral Enteritis, Inclusion Body Hepatitis, Salmonella, Others)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Product Market Map
5.3.1. By Application
5.3.2. By Product
5.3.3. By Disease Type
5.3.4. By Region
6. NORTH AMERICA POULTRY VACCINES MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Application (Broiler, Layer, Breeder)
6.2.2. By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines)
6.2.3. By Disease Type (Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus, Duck Viral Enteritis, Inclusion Body Hepatitis, Salmonella, Others)
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Poultry Vaccines Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Application
6.3.1.2.2. By Product
6.3.1.2.3. By Disease Type
6.3.2. Canada Poultry Vaccines Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Application
6.3.2.2.2. By Product
6.3.2.2.3. By Disease Type
6.3.3. Mexico Poultry Vaccines Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Application
6.3.3.2.2. By Product
6.3.3.2.3. By Disease Type
7. EUROPE POULTRY VACCINES MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Application (Broiler, Layer, Breeder)
7.2.2. By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines)
7.2.3. By Disease Type (Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus, Duck Viral Enteritis, Inclusion Body Hepatitis, Salmonella, Others)
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Poultry Vaccines Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Application
7.3.1.2.2. By Product
7.3.1.2.3. By Disease Type
7.3.2. United Kingdom Poultry Vaccines Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Application
7.3.2.2.2. By Product
7.3.2.2.3. By Disease Type
7.3.3. France Poultry Vaccines Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Application
7.3.3.2.2. By Product
7.3.3.2.3. By Disease Type
7.3.4. Italy Poultry Vaccines Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Application
7.3.4.2.2. By Product
7.3.4.2.3. By Disease Type
7.3.5. Spain Poultry Vaccines Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Application
7.3.5.2.2. By Product
7.3.5.2.3. By Disease Type
8. ASIA-PACIFIC POULTRY VACCINES MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Application (Broiler, Layer, Breeder)
8.2.2. By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines)
8.2.3. By Disease Type (Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus, Duck Viral Enteritis, Inclusion Body Hepatitis, Salmonella, Others)
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Poultry Vaccines Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Application
8.3.1.2.2. By Product
8.3.1.2.3. By Disease Type
8.3.2. Japan Poultry Vaccines Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Application
8.3.2.2.2. By Product
8.3.2.2.3. By Disease Type
8.3.3. India Poultry Vaccines Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Application
8.3.3.2.2. By Product
8.3.3.2.3. By Disease Type
8.3.4. Australia Poultry Vaccines Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Application
8.3.4.2.2. By Product
8.3.4.2.3. By Disease Type
8.3.5. South Korea Poultry Vaccines Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Application
8.3.5.2.2. By Product
8.3.5.2.3. By Disease Type
9. SOUTH AMERICA POULTRY VACCINES MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Application (Broiler, Layer, Breeder)
9.2.2. By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines)
9.2.3. By Disease Type (Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus, Duck Viral Enteritis, Inclusion Body Hepatitis, Salmonella, Others)
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Poultry Vaccines Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Application
9.3.1.2.2. By Product
9.3.1.2.3. By Disease Type
9.3.2. Argentina Poultry Vaccines Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Application
9.3.2.2.2. By Product
9.3.2.2.3. By Disease Type
9.3.3. Colombia Poultry Vaccines Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Application
9.3.3.2.2. By Product
9.3.3.2.3. By Disease Type
10. MIDDLE EAST AND AFRICA POULTRY VACCINES MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Application (Broiler, Layer, Breeder)
10.2.2. By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines)
10.2.3. By Disease Type (Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus, Duck Viral Enteritis, Inclusion Body Hepatitis, Salmonella, Others)
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Poultry Vaccines Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Application
10.3.1.2.2. By Product
10.3.1.2.3. By Disease Type
10.3.2. Saudi Arabia Poultry Vaccines Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Application
10.3.2.2.2. By Product
10.3.2.2.3. By Disease Type
10.3.3. UAE Poultry Vaccines Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Application
10.3.3.2.2. By Product
10.3.3.2.3. By Disease Type
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches
13. PORTER’S FIVE FORCES ANALYSIS
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products
14. COMPETITIVE LANDSCAPE
14.1. Boehringer Ingelheim GmbH
14.1.1. Business Overview
14.1.2. Company Snapshot
14.1.3. Products & Services
14.1.4. Financials (As Reported)
14.1.5. Recent Developments
14.1.6. Key Personnel Details
14.1.7. SWOT Analysis
14.2. Zoetis Inc
14.3. Elanco LLC
14.4. Intervet Inc
14.5. Hester Biosciences Ltd
14.6. Vaxxinova GmbH
14.7. Venky's India Ltd
14.8. Laboratorios Calier SA
14.9. KM Biologics Co Ltd
14.10. Phibro Animal Health Corporation
15. STRATEGIC RECOMMENDATIONS
16. ABOUT US & DISCLAIMER
